HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses.

Abstract
T cells infiltrating tumors have a decreased expression of signal transduction proteins, a diminished ability to proliferate, and a decreased production of cytokines. The mechanisms causing these changes have remained unclear. We demonstrated recently that peritoneal macrophages stimulated with interleukin 4 + interleukin 13 produce arginase I, which decreases the expression of the T-cell receptor CD3zeta chain and impairs T-cell responses. Using a 3LL murine lung carcinoma model we tested whether arginase I was produced in the tumor microenvironment and could decrease CD3zeta expression and impair T-cell function. The results show that a subpopulation of mature tumor-associated myeloid cells express high levels of arginase I, whereas tumor cells and infiltrating lymphocytes do not. Arginase I expression in the tumor was seen on day 7 after tumor injection. Tumor-associated myeloid cells also expressed high levels of cationic amino acid transporter 2B, which allowed them to rapidly incorporate L-Arginine (L-Arg) and deplete extracellular L-Arg in vitro. L-Arg depletion by tumor-associated myeloid cells blocked the re-expression of CD3zeta in stimulated T cells and inhibited antigen-specific proliferation of OT-1 and OT-2 cells. The injection of the arginase inhibitor N-hydroxy-nor-L-Arg blocked growth of s.c. 3LL lung carcinoma in mice. High levels of arginase I were also found in tumor samples of patients with non-small cell carcinoma. Therefore, arginase I production by mature myeloid cells in the tumor microenvironment may be a central mechanism for tumor evasion and may represent a target for new therapies.
AuthorsPaulo C Rodriguez, David G Quiceno, Jovanny Zabaleta, Blair Ortiz, Arnold H Zea, Maria B Piazuelo, Alberto Delgado, Pelayo Correa, Jason Brayer, Eduardo M Sotomayor, Scott Antonia, Juan B Ochoa, Augusto C Ochoa
JournalCancer research (Cancer Res) Vol. 64 Issue 16 Pg. 5839-49 (Aug 15 2004) ISSN: 0008-5472 [Print] United States
PMID15313928 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • CD3 Complex
  • CD3 antigen, zeta chain
  • Epitopes, T-Lymphocyte
  • Receptors, Antigen, T-Cell
  • Arginase
Topics
  • Amino Acid Sequence
  • Animals
  • Arginase (antagonists & inhibitors, biosynthesis, immunology)
  • CD3 Complex (biosynthesis, immunology)
  • Carcinoma, Lewis Lung (enzymology, immunology, pathology)
  • Carcinoma, Non-Small-Cell Lung (enzymology, immunology, pathology)
  • Cell Division (physiology)
  • Epitopes, T-Lymphocyte (immunology)
  • Female
  • Humans
  • Lung Neoplasms (enzymology, immunology, pathology)
  • Lymphocyte Activation (immunology)
  • Mice
  • Molecular Sequence Data
  • Myeloid Cells (enzymology, immunology)
  • Receptors, Antigen, T-Cell (antagonists & inhibitors, biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: